Stephen J. Zoog, Ph.D. - Publications
Affiliations: | 2000 | University of Wisconsin, Madison, Madison, WI |
Area:
Biochemistry, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Kaplan-Lefko PJ, Graves JD, Zoog SJ, Pan Y, Wall J, Branstetter DG, Moriguchi J, Coxon A, Huard JN, Xu R, Peach ML, Juan G, Kaufman S, Chen Q, Bianchi A, et al. Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biology & Therapy. 9: 618-31. PMID 20150762 | 0.382 | |||
2002 | Zoog SJ, Schiller JJ, Wetter JA, Chejanovsky N, Friesen PD. Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. The Embo Journal. 21: 5130-40. PMID 12356729 DOI: 10.1038/Sj.Emboj.7594736 | 0.605 | |||
1999 | Zoog SJ, Bertin J, Friesen PD. Caspase inhibition by baculovirus P35 requires interaction between the reactive site loop and the beta-sheet core. The Journal of Biological Chemistry. 274: 25995-6002. PMID 10473544 DOI: 10.1074/Jbc.274.37.25995 | 0.6 | |||
1999 | Fisher AJ, Cruz Wd, Zoog SJ, Schneider CL, Friesen PD. Crystal structure of baculovirus P35: role of a novel reactive site loop in apoptotic caspase inhibition. The Embo Journal. 18: 2031-9. PMID 10205157 DOI: 10.1093/Emboj/18.8.2031 | 0.614 | |||
Show low-probability matches. |